Troponin Levels Identify CAD Patients Likely to Benefit from Tirofiban: Results from the PRISM-Troponin Study, A substudy of the Platelet Receptor Inhibition in Ischemic Syndrome Management Study - PRISM-Troponin

Description:

The goal of the substudy was to assess the efficacy of early troponin measurements as a criterion for selecting patients most likely to respond to glycoprotein IIb/IIIa inhibitor therapy.